Published in:
Open Access
01-12-2018 | Letter
Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
Authors:
Patrick M. Honore, David De Bels, Thierry Preseau, Sebastien Redant, Rachid Attou, Herbert D. Spapen
Published in:
Critical Care
|
Issue 1/2018
Login to get access
Excerpt
We read with interest the excellent review of Spoelstra-de Man et al. which focused on the potential benefit of adjuvant vitamin C (vit C) therapy in ischemia-reperfusion injury [
1]. Following an exhaustive in-depth analysis of the impressive experimental, clinical, and safety record of vit C, the authors plead for a randomized controlled clinical trial assessing the effect of early, high-dose (i.e., at least 3 g/day), intravenous vit C administration in post-cardiac arrest patients. …